Surviving breast cancer heightens awareness of bodily changes, with new symptoms potentially triggering fears of recurrence.

Immunotherapies, such as the blockbuster immune checkpoint inhibitor drug Keytruda (pembrolizumab), work by keeping cancer cells from suppressing a patient’s immune system and thus allowing the immune ...

Squamous cell carcinoma (SCC) of the bladder is a distinct and rarer form, accounting for approximately 2% to 5% of all bladder cancers in the U.S. It develops in the flat, thin squamous cells that ...

The FDA granted fast track designation to AVZO-103 for the treatment of patients with previously treated locally advanced or metastatic urothelial cancer.

Advances in surgery and a clearer understanding of early stage lung cancer are improving outcomes for many patients. Dr. Nabil Rizk, chief of thoracic surgery at Hackensack University Medical Center ...

Dr. Charles M. Rudin highlighted new small cell lung cancer therapies, including T cell engagers, antibody-drug conjugates, ...

The phase 2 SANRECO study has recently completed enrollment and will evaluate divesiran, a potential therapy for patients ...

Grief intertwines with holiday traditions, creating a complex emotional landscape where joy and sorrow coexist, reflecting the depth of love and loss. The natural human process of grief is intensified ...

Sac-TMT combined with Keytruda significantly improves progression-free survival in PD-L1-positive advanced non-small cell ...

Voranigo (vorasidenib), a drug for certain brain tumors, was safe and well toleratedin patients with grade 3 or 4 IDH-mutant ...

In observation of Neuroendocrine Tumors (NETs) Awareness Month, Dr. Pamela L. Kunz sat down for an interview with CURE to ...

Panelists discuss how patients beginning talquetamab should maintain a positive attitude, prepare thoroughly with educational ...